Oruka Therapeutics, Inc.(ORKA US)
$105.35+0.360.34%
- Pricing and plans
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY200512/31/2005 | FY200612/31/2006 | FY200712/31/2007 | FY200812/31/2008 | FY200912/31/2009 | FY201012/31/2010 | FY201112/31/2011 | FY201212/31/2012 | FY201312/31/2013 | FY201412/31/2014 | FY201512/31/2015 | FY201612/31/2016 | FY201712/31/2017 | FY201812/31/2018 | FY201912/31/2019 | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | 37.4 | 61.6 | 46.9 | 49.5 | ||||||||||||||||||||
| Short Term Investments | - | 314.1 | 290.1 | 339.3 | ||||||||||||||||||||
| Cash and Short Term Investments | 37.4 | 375.6 | 337.0 | 388.8 | ||||||||||||||||||||
| Net Receivables | - | - | - | - | ||||||||||||||||||||
| Inventory | - | - | - | - | ||||||||||||||||||||
| Other Current Assets | 0.2 | 1.2 | 6.8 | 6.4 | ||||||||||||||||||||
| Total Current Assets | 37.6 | 376.9 | 343.9 | 395.2 | ||||||||||||||||||||
| Property, Plant & Equipment | 0.3 | 1.0 | 2.1 | 2.0 | ||||||||||||||||||||
| Long Term Investments | - | 18.1 | 142.5 | 107.1 | ||||||||||||||||||||
| Other Non-Current Assets | 0.0 | 0.0 | 0.1 | 0.1 | ||||||||||||||||||||
| Total Non-Current Assets | 0.3 | 19.2 | 144.8 | 109.2 | ||||||||||||||||||||
| Total Assets | 37.9 | 396.0 | 488.6 | 504.5 | ||||||||||||||||||||
| Account Payables | - | 3.5 | 4.2 | 3.7 | ||||||||||||||||||||
| Short Term Debt | 0.1 | 0.2 | 0.6 | 0.7 | ||||||||||||||||||||
| Deferred Revenue | - | - | - | - | ||||||||||||||||||||
| Other Current Liabilities | 0.5 | 7.3 | 5.3 | 10.6 | ||||||||||||||||||||
| Total Current Liabilities | 0.6 | 13.0 | 15.4 | 16.6 | ||||||||||||||||||||
| Long Term Debt | - | - | - | - | ||||||||||||||||||||
| Other Non-Current Liabilities | - | - | - | - | ||||||||||||||||||||
| Total Non-Current Liabilities | 0.2 | 0.8 | 1.3 | 1.1 | ||||||||||||||||||||
| Total Liabilities | 0.8 | 13.8 | 16.7 | 17.8 | ||||||||||||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.1 | ||||||||||||||||||||
| Retained Earnings | -188.7 | -83.7 | -189.2 | -221.0 | ||||||||||||||||||||
| Total Stockholders Equity | 37.0 | 382.2 | 471.9 | 486.7 | ||||||||||||||||||||
| Total Liabilities and Equity | 37.9 | 396.0 | 488.6 | 504.5 | ||||||||||||||||||||
| Millions USD (ex. Per Share) | FY200512/31/2005 | FY200612/31/2006 | FY200712/31/2007 | FY200812/31/2008 | FY200912/31/2009 | FY201012/31/2010 | FY201112/31/2011 | FY201212/31/2012 | FY201312/31/2013 | FY201412/31/2014 | FY201512/31/2015 | FY201612/31/2016 | FY201712/31/2017 | FY201812/31/2018 | FY201912/31/2019 | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | 37.4 | 61.6 | 46.9 | 49.5 | ||||||||||||||||||||
| Short Term Investments | - | 314.1 | 290.1 | 339.3 | ||||||||||||||||||||
| Cash and Short Term Investments | 37.4 | 375.6 | 337.0 | 388.8 | ||||||||||||||||||||
| Net Receivables | - | - | - | - | ||||||||||||||||||||
| Inventory | - | - | - | - | ||||||||||||||||||||
| Other Current Assets | 0.2 | 1.2 | 6.8 | 6.4 | ||||||||||||||||||||
| Total Current Assets | 37.6 | 376.9 | 343.9 | 395.2 | ||||||||||||||||||||
| Property, Plant & Equipment | 0.3 | 1.0 | 2.1 | 2.0 | ||||||||||||||||||||
| Long Term Investments | - | 18.1 | 142.5 | 107.1 | ||||||||||||||||||||
| Other Non-Current Assets | 0.0 | 0.0 | 0.1 | 0.1 | ||||||||||||||||||||
| Total Non-Current Assets | 0.3 | 19.2 | 144.8 | 109.2 | ||||||||||||||||||||
| Total Assets | 37.9 | 396.0 | 488.6 | 504.5 | ||||||||||||||||||||
| Account Payables | - | 3.5 | 4.2 | 3.7 | ||||||||||||||||||||
| Short Term Debt | 0.1 | 0.2 | 0.6 | 0.7 | ||||||||||||||||||||
| Deferred Revenue | - | - | - | - | ||||||||||||||||||||
| Other Current Liabilities | 0.5 | 7.3 | 5.3 | 10.6 | ||||||||||||||||||||
| Total Current Liabilities | 0.6 | 13.0 | 15.4 | 16.6 | ||||||||||||||||||||
| Long Term Debt | - | - | - | - | ||||||||||||||||||||
| Other Non-Current Liabilities | - | - | - | - | ||||||||||||||||||||
| Total Non-Current Liabilities | 0.2 | 0.8 | 1.3 | 1.1 | ||||||||||||||||||||
| Total Liabilities | 0.8 | 13.8 | 16.7 | 17.8 | ||||||||||||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.1 | ||||||||||||||||||||
| Retained Earnings | -188.7 | -83.7 | -189.2 | -221.0 | ||||||||||||||||||||
| Total Stockholders Equity | 37.0 | 382.2 | 471.9 | 486.7 | ||||||||||||||||||||
| Total Liabilities and Equity | 37.9 | 396.0 | 488.6 | 504.5 | ||||||||||||||||||||